Department of Neurology, Keio Universrity School of Medicine, Tokyo, Japan.
Neurovascular Research Unit, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States; Stroke Service, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Prog Brain Res. 2020;255:29-67. doi: 10.1016/bs.pbr.2020.05.009. Epub 2020 Jun 27.
Migraine is among the most common and disabling neurological diseases in the world. Cortical spreading depression (CSD) is a wave of near-complete depolarization of neurons and glial cells that slowly propagates along the cortex creating the perception of aura. Evidence suggests that CSD can trigger migraine headache. Experimental models of CSD have been considered highly translational as they recapitulate migraine-related phenomena and have been validated for screening migraine therapeutics. Here we outline the essential components of validated experimental models of CSD and provide a comprehensive review of potential modulators and targets against CSD. We further focus on novel interventions that have been recently shown to suppress CSD susceptibility that may lead to therapeutic targets in migraine.
偏头痛是世界上最常见和最具致残性的神经系统疾病之一。皮质扩散性抑制(CSD)是神经元和神经胶质细胞的近乎完全去极化波,它沿着皮质缓慢传播,产生先兆的感觉。有证据表明,CSD 可以引发偏头痛。CSD 的实验模型被认为具有高度的转化性,因为它们再现了与偏头痛相关的现象,并已被验证用于筛选偏头痛治疗药物。在这里,我们概述了经过验证的 CSD 实验模型的基本组成部分,并对潜在的 CSD 调节剂和靶点进行了全面综述。我们进一步关注最近显示可抑制 CSD 易感性的新干预措施,这些措施可能成为偏头痛的治疗靶点。
Prog Brain Res. 2020
Headache. 2017-8-26
J Headache Pain. 2019-5-2
Nat Rev Neurol. 2013-9-17
Cephalalgia. 2018-4-25
Curr Neurol Neurosci Rep. 2010-5
J Cereb Blood Flow Metab. 2018-4-13
Agri. 2006-10
Nat Rev Neurol. 2025-8-14
J Headache Pain. 2025-7-16
J Headache Pain. 2024-12-19
J Headache Pain. 2024-10-2
Neurobiol Pain. 2022-4-9